The Ophthalmologist

Welcome to first 2018 issue of The Ophthalmologist! In Upfront, topics including surprising benefits of drinking hot tea and a silent approach to treating AMD are featured. In My View sees Theo Seiler, Farhad Hafezi, J. Bradley Randleman and Paolo Vinciguerra challenge CXLUSA’s approach for corneal crosslinking. Our feature focuses on what eye surgeons get up to outside the clinic, and Howard Fine and Günther Grabner share their stories and the benefits they have found. In Practice sees Virender Sangwan discuss the benefits of SLET for limbal stem cell deficiency, and in NextGen, Sean McCafferty introduces CATS, a tonometer prism which can account for corneal variability. In Profession, the challenges facing eyecare in Cambodia are discussed, and one team share their mission to serve this vastly underserved population. Finally, we Sit Down With Tom Frinzi, Worldwide President of Johnson & Johnson Vision, Surgical.

PanOptix™: Demonstrating the Evidence

January 10, 2018

An update on clinical evidence for the PanOptix™ trifocal IOL

1 min read

Ophthalmology's Indiana Jones with Gunther Grabner

January 9, 2018

with Günther Grabner

1 min read

Ophthalmology's Indiana Jones with Gunther Grabner

Retirement done right

January 9, 2018

1 min read

Creating Your Own Masterpiece with Howard Fine

January 9, 2018

with Howard Fine

1 min read

Ophthalmologists and the Outside World

January 9, 2018

Howard Fine on how external influences shaped his practice of ophthalmology, and Günther Grabner on how a career in ophthalmology shaped what he did next: archaeology

1 min read

CXLUSA: Show Us Your Hand

January 9, 2018

Poorly managed epi-on CXL risks trashing the technique’s reputation – and we’re yet to be convinced of CXLUSA’s effectiveness. A response to Roy Rubinfeld’s “Time to Drop the Debate” (1).

1 min read